Trial site
University of Minnesota/Masonic Children's Hospital
- 10running trials
- 4closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers4 trials
- Neuroblastoma2 trials
- Obesity2 trials
- Acute lymphoblastic leukaemia1 trial
- Congenital heart disease1 trial
- Fabry disease1 trial
- Haemophagocytic lymphohistiocytosis1 trial
- IgA nephropathy1 trial
- Lupus (SLE)1 trial
- Nephrotic syndrome1 trial
- Pancreatic cancer1 trial
- Sarcoma1 trial
- and 1 more
- Phase
- Phase 35 trials
- Phase 22 trials
- Phase 2/32 trials
- Early phase 11 trial
- Phase 1/21 trial
- Status
- Recruiting6 trials
- Completed4 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- Eli Lilly and Company2 trials
- Acacia Pharma Ltd1 trial
- Amicus Therapeutics1 trial
- Children's Hospital Medical Center, Cincinnati1 trial
- Children's Hospital of Philadelphia1 trial
- and 8 more
Running trials
Recruiting
Recruiting
A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients
Recruiting
Recruiting
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Active, not recruiting
Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures
Recruiting
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Recruiting
Enrolling by invitation
Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy
Recruiting
Quality of Pediatric Resuscitation in a Multicenter Collaborative
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Childhood cancers1 recruiting
- Congenital heart disease1 recruiting
- Fabry disease1 recruiting
- IgA nephropathy1 recruiting
- Nephrotic syndrome1 recruiting
- Neuroblastoma1 recruiting
- Pancreatic cancer1 recruiting
- Sickle cell disease1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas
Site data: ClinicalTrials.govUpdated 17 Nov 2026